PateƱo, Cecile P.
HRN: 28-90-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/29/2026
05/07/2026
IV
500mg
Q8
S/P Laminectomy With Discectomy
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Bone & JointCentral Nervous System Compliance to guidelines: Compliant To Guidelines